Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

3 structures for Q9DC40

Entry ID Method Resolution Chain Position Source
4CKT X-ray 300 A C/D 489-496 PDB
4CSE X-ray 330 A C/D 488-496 PDB
AF-Q9DC40-F1 Predicted AlphaFoldDB

63 variants for Q9DC40

Variant ID(s) Position Change Description Diseaes Association Provenance
rs13471498 18 I>T No EVA
rs215185646 18 I>V No EVA
rs3389449844 29 L>P No EVA
rs3389435499 35 L>Q No EVA
rs251273966 43 E>K No EVA
rs3407438638 79 P>T No EVA
rs3389449855 80 G>C No EVA
rs260473419 80 G>D No EVA
rs3389440756 84 E>D No EVA
rs227959182 85 R>Q No EVA
rs3389443403 91 F>V No EVA
rs3389421413 98 Q>P No EVA
rs3389459460 102 V>M No EVA
rs3389421407 110 T>I No EVA
rs3389453959 112 G>D No EVA
rs3389391276 135 A>T No EVA
rs3389421425 141 C>Y No EVA
rs3389391236 148 S>G No EVA
rs3389444700 157 L>I No EVA
rs3389432942 171 L>F No EVA
rs33575363 205 D>G No EVA
rs3389443360 220 K>E No EVA
rs33779993 272 V>I No EVA
rs3389443290 283 R>* No EVA
rs3389444717 289 V>M No EVA
rs50122533 301 R>C No EVA
rs3389391247 302 K>M No EVA
rs3389432930 321 Y>H No EVA
rs3389421474 342 T>I No EVA
rs3389432907 370 H>L No EVA
rs33782498 372 G>R No EVA
rs233076040 408 I>T No EVA
rs3407589497 438 L>M No EVA
rs238883375 443 P>L No EVA
rs33784084 446 A>V No EVA
rs239322246 447 G>S No EVA
rs48725187 461 V>A No EVA
rs33784088 465 S>P No EVA
rs3389449840 467 V>E No EVA
rs259523770 474 V>M No EVA
rs3407427142 474 V>P No EVA
rs3389440776 505 R>I No EVA
rs33776714 509 S>N No EVA
rs230613679 512 E>Q No EVA
rs33776715 520 V>M No EVA
rs3389403415 525 T>R No EVA
rs33776718 531 R>H No EVA
rs3389411942 543 V>L No EVA
rs33776719 548 T>A No EVA
rs3389403473 572 E>K No EVA
rs3389443332 622 Q>E No EVA
rs265247713 638 P>S No EVA
rs245263695 639 P>L No EVA
rs3389391261 640 V>L No EVA
rs33777416 651 V>I No EVA
rs3389444702 662 W>* No EVA
rs33777417 664 V>M No EVA
rs3389432962 768 R>S No EVA
rs3389435423 769 R>D No EVA
rs3389432990 774 A>T No EVA
rs13471497 775 V>M No EVA
rs33779306 812 E>K No EVA
rs3389451553 824 L>I No EVA

No associated diseases with Q9DC40

1 regional properties for Q9DC40

Type Name Position InterPro Accession
domain Telomere length regulation protein, conserved domain 513 - 621 IPR019337

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Membrane
  • Nucleus
  • Chromosome, telomere
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

11 GO annotations of cellular component

Name Definition
ASTRA complex A protein complex that is part of the chromatin remodeling machinery; the acronym stands for ASsembly of Tel, Rvb and Atm-like kinase. In Saccharomyces cerevisiae this complex includes Rvb1p, Rvb2p, Tra1p, Tel2p, Asa1p, Ttilp and Tti2p.
chromosome, telomeric region The end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres).
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
nuclear body Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
nuclear periphery The portion of the nuclear lumen proximal to the inner nuclear membrane.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
TORC1 complex A protein complex that contains at least TOR (target of rapamycin) and Raptor (regulatory-associated protein of TOR), or orthologs of, in complex with other signaling components. Mediates the phosphorylation and activation of S6K. In Saccharomyces, the complex contains Kog1p, Lst8p, Tco89p, and either Tor1p or Tor2p.
TORC2 complex A protein complex that contains at least TOR (target of rapamycin) and Rictor (rapamycin-insensitive companion of TOR), or orthologs of, in complex with other signaling components. Mediates the phosphorylation and activation of PKB (also called AKT). In Saccharomyces, the complex contains Avo1p, Avo2p, Tsc11p, Lst8p, Bit61p, Slm1p, Slm2p, and Tor2p.
TTT complex A protein complex responsible for the stabilisation of protein levels of the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins. The TTT complex can also be found as part of the ASTRA complex (GO:0070209).

5 GO annotations of molecular function

Name Definition
Hsp90 protein binding Binding to Hsp90 proteins, any of a group of heat shock proteins around 90kDa in size.
molecular adaptor activity The binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
protein kinase binding Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
protein-containing complex binding Binding to a macromolecular complex.
telomeric DNA binding Binding to a telomere, a specific structure at the end of a linear chromosome required for the integrity and maintenance of the end.

6 GO annotations of biological process

Name Definition
positive regulation of protein serine/threonine kinase activity Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity.
positive regulation of TORC1 signaling Any process that activates or increases the frequency, rate or extent of TORC1 signaling.
positive regulation of TORC2 signaling Any process that activates or increases the frequency, rate or extent of TORC2 signaling.
protein stabilization Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
regulation of TOR signaling Any process that modulates the frequency, rate or extent of TOR signaling.
telomere maintenance via telomerase The maintenance of proper telomeric length by the addition of telomeric repeats by telomerase.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P53038 TEL2 Telomere length regulation protein TEL2 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q9Y4R8 TELO2 Telomere length regulation protein TEL2 homolog Homo sapiens (Human) PR
10 20 30 40 50 60
MDPALSAVRL TVQEAIHILS SSEDAGHILS TLGTLKRYLG GTEDPVLPEE KEEFATVHFS
70 80 90 100 110 120
AVLRCLVSKL SPGWLELSPG GQLERLWESF FLDGPPDQAF LVLMEAIEST AGPSFRLMKM
130 140 150 160 170 180
AQLLDTFLST GRVAALMEEQ CRPQTKPSFP LFQETLLSKV VGLPDLLGNC LQRDNLTQFF
190 200 210 220 230 240
PQNYFPLLGQ EVVQALKAVV NFLQDGLDCS VSFVSRVLGK VCIQGRKREI LSVLVPQLTV
250 260 270 280 290 300
LTQDSCLWQR VCWRLVEQVP DRAVEAVLTG LVEAAPRPEV LSRLLGNLVV KNKKARFVVT
310 320 330 340 350 360
RKLLLLQYQH TTPMVQSLLG YLALDSQRRP LLIQVLKELL ETWGCSSAVR HTPLEQQCYI
370 380 390 400 410 420
SKAILVCLAH LGEPELQDIR DELLASMMAG VKCRLDSSLP PVRRLGMIVA EVISSRIHPE
430 440 450 460 470 480
GPLLKFQYED DEMSRELLAL ATPEPAGDCS SVSRGPSPAP VDTESPVEMP EKAVESDVPP
490 500 510 520 530 540
TQPQGSDSEL DSDDEFIPYD MSGDRELKSS KEPLYIRDCV EALTTSEDME RWEASLKGLE
550 560 570 580 590 600
GLVYRSPTAT REVSVELAKV LLHLEEKTCV AEFEQLRQSA LVAVTVTDPE QVAKYLTSQF
610 620 630 640 650 660
YGLNYSLRQR MDILDVLVLA AQALSRPKSL QRRSQHGPPV PGTMCSPALA VSQTGNVAAP
670 680 690 700 710 720
DWQVVVEERI RSKTRRFSKG CPQRELSGVP NEFSSVAGYF FFPLLQHFDR PLVTFDLLGD
730 740 750 760 770 780
DQLVLGRLTH TLASLMYLAV NTTVAVPMGK ALLEFVWALR FHVDIYVRRG LLSAVSSVLL
790 800 810 820 830
SVPTERLLGD LPDELLEARS WLADVAEKDV DEDCRELAVR ALLLLERLKD KLLSSSSPQP